Live from the NIH registry
Studies recruiting near Fort Collins right now
Top 25 of 155 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Fort Collins, Colorado (2.8 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites
Microbiome Analysis, Metabolomics
N/A
Interventional 125 participants sought
Colorado State University; Food and Nutrition Clinical Research Laboratory; Gifford Building Room 216; 502 West Lake Street, Fort Collins, CO 80523 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Global Paradise System US Post Approval Study
Hypertension, Cardiovascular Diseases
N/A
Observational 1,000 participants sought
Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: ReCor Medical, Inc.
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Phase 3
Interventional 844 participants sought
Tekton Research, LLC - 2121 E Harmony Rd - PPDS — Fort Collins, Colorado (2.8 mi)
· Sponsor: Amgen
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: NRG Oncology
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Eye Center of Northern Colorado /ID# 281798 — Fort Collins, Colorado (2.8 mi)
· Sponsor: AbbVie
The Impact of Enhanced Music & Natural Visuals on Emotional Health
Emotion Management Skills, Lifestyle, Healthy
N/A
Interventional 200 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: soundBrilliance LLC
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Pfizer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Rocky Mountain Cancer Centers, LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Pfizer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Orthopaedic and Spine Center of the Rockies — Fort Collins, Colorado (2.8 mi)
· Sponsor: Exactech
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
UCHealth Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Orchestra BioMed, Inc
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1014 — Fort Collins, Colorado (2.8 mi)
· Sponsor: Immunovant Sciences GmbH
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Advanced Neurology of Colorado — Fort Collins, Colorado (2.8 mi)
· Sponsor: Genentech, Inc.
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
Metatarsus Adductus, Hallux Valgus
N/A
Interventional 80 participants sought
Foot and Ankle Center of the Rockies — Greeley, Colorado (20.6 mi)
· Sponsor: Treace Medical Concepts, Inc.
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastroesophageal-junction Cancer, Monoclonal Antibody
Phase 3
Interventional 550 participants sought
Banner MD Anderson Cancer Center — Greeley, Colorado (20.6 mi)
· Sponsor: Shanghai Henlius Biotech
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute — Longmont, Colorado (26.4 mi)
· Sponsor: Regeneron Pharmaceuticals
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Canadian Cancer Trials Group
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Metastatic Breast Cancer
Phase 1, Phase 2
Interventional 1,132 participants sought
Rocky Mountain Cancer Center - Longmont — Longmont, Colorado (26.4 mi)
· Sponsor: Hoffmann-La Roche